INTRODUCTION AND OBJECTIVES: Four groups of rats were used: young rats (7 months) þ ad-libitum, old rats (22 months) þ ad-libitum, young rats þ CR diet, and old rats þ CR diet. The ad-libitum group had free access to both food and water and CR groups were fed 60% of the food intake of their ad-libitum littermates, for 6 weeks before decapitation. The penis was harvested and stained with antibodies to vWF, smooth muscle a-actin, PDGFR-b, neurofillament, and S100. We also performed Masson trichrome staining and TUNNEL assay. The blood samples were collected for the measurement of plasma testosterone level.
INTRODUCTION AND OBJECTIVES: Soluble epoxide hydrolase (sEH) can catalyze epoxyeicosatrienoic acids (EETs) to dihydroxyepoxytrienoic acids (DHETs), thereby reduces their biological activity, such as vasodilation and anti-apoptosis. We performed this study to investigate the effect of inhibition of sEH on the diabetic erectile dysfunction in mice.
METHODS: Diabetes was induced in 8-week old male mice by introperitoneal injection of streptozotocin with the dose of 60mg/kg for 5 consecutive days. 16 weeks after the induction the mice were divided into 3 groups (8 mice in each group): (1) nondiabetic control group, (2) diabetic mice þ vehicle group which were given tap water containing 0.01% DMSO for 4 weeks, and (3) diabetic mice þ trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB) group, which received t-AUCB (an inhibitor of sEH, 2mg/L in drinking water containing 0.01% DMSO) for 4 weeks. Then erectile function of mice was measured by electrical stimulation of the cavernous nerve and ratio between intracavernosal pressure (ICP) and mean systemic arterial blood pressure (MAP) at the peak of erectile response was calculated. After that penis tissue was harvested. Expression of sEH, transforming growth factor beta 1 (TGFß-1) and collagen IV in corpus cavernosum were measured by western blot. The deposition of extracellular collagen was determined by Masson trichrome staining, while the content of a-smooth muscle actin (a-SMA) was measured by immunofluorescence. Apoptosis was detected by terminal dexynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL).
RESULTS: The ICP/MAP was reduced in diabetic mice compared with control group, but was improved by t-AUCB treatment (p<0.05). The expression of sEH, TGFß-1 and collagen IV were all decreased by giving t-AUCB in diabetic mice (p<0.05). The ratio of smooth muscle to collagen and the content of a-SMA were both increased in t-AUCB group compared with vehicle group (p<0.05). Besides, less apoptotic cells were found in t-AUCB group than in the vehicle group (p<0.05).
CONCLUSIONS: sEH might play a role in the development of diabetic erectile dysfunction. Inhibition of sEH could improve the erectile function in diabetic mice by reducing the fibrosis and apoptosis in corpus cavernosum.
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MP45-20 IMPROVEMENT OF PENILE HISTOMORPHOLOGICAL STRUCTURE AND FUNCTION WITH STEM CELLS IN A RAT MODEL OF NEUROVASCULAR ERECTILE DYSFUNCTION
Ting Long, Liren Zhong, Hua Shi, Yuanyuan Zhang, Wei Li, Dong Chen, HyunChul Chung, Cara Clouse, Sandy Sink, sunil George, Winston Salem, NC; Tom Lue, San Francisco, CA; James Yoo, Anthony Atala, John Jackson*, Winston Salem, NC INTRODUCTION AND OBJECTIVES: Neurovascular injury induced erectile dysfunction is a common complication in complex pelvic trauma in men. This lesion remains difficult to treat despite advances in pharmacotherapeutic approaches. The goal of this study is to determine whether stem cells implanted into the corpora cavernosa could improve erectile function and restore histomorphological structure in a rat model of neurovascular erectile dysfunction (NVED). METHODS: NVED model was established in athymic rats by crushing bilateral cavernous nerves and ligations of bilateral internal pudendal bundles. Three different types of human stem cells were used: endothelial cells (ECs), adipose derived stem cells (ASCs) and amniotic fluid derived stem cells (AFSCs). Normal saline injection served as a control. Stem cells (2.5x10 6 cells/0.2 ml) were injected intracavernously into the penile tissue. Erectile function and histomorphological analyses of penile tissue were assessed 12 weeks after stem cell injection.
RESULTS: The ratio of intracavernous pressure and mean artery pressure (functional indicator) was increased in the stem cell and endothelial cell therapy groups when compared to the NS injection group. Immunofluorescence staining showed that more cells expressing biomarkers of endothelial, smooth muscle, and nerve cells within the corpora cavernosa was seen in the cell therapy groups when compared to the NS injection group.
CONCLUSIONS: Stem cell therapy enhanced erectile function and ameliorated the histological structure in NVED rats, indicating that stem cell therapy may induce vascular, myogenic and neurogenic tissue regeneration in a rat model of NVED.
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